EMA considers stakeholder debate on allowing progressive licensing
This article was originally published in SRA
Executive Summary
The European Medicines Agency's finalised "Road Map to 2015" indicates that the agency intends to launch a debate on the appropriateness of introducing staggered approvals (or progressive licensing) for human medicines1,2.